Form 4 holding
Chief Financial & Operating Officer
Aardvark Therapeutics, Inc.
- Security class
- Common Stock, par value $0.00001 per share
- Shares / value
- 35,475
- Estimated value
- $183,771
- Report date
- 11 Sep 2026
- Price
- $5.18
- Ownership
- Direct